GAL-101
Tier C — Watch / tradeGAL-101
Targets:APP
Indications (approved):Alzheimer's disease, 地图状萎缩, Glaucoma
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| MRZ-99030-001 | 5241-64-5 | (tert-butoxycarbonyl)-D-tryptophan |
| MRZ-99030-002 | - | benzyl 2-amino-2-methylpropanoate hydrochloride |
| MRZ-99030-003 | - | benzyl (R)-2-(2-((tert-butoxycarbonyl)amino)-3-(1H-indol-3-yl)propanamido)-2-methylpropanoate |
| MRZ-99030-004 | - | benzyl (R)-2-(2-amino-3-(1H-indol-3-yl)propanamido)-2-methylpropanoate |
| MRZ-99030 | 1123071-24-8 | (R)-2-(2-amino-3-(1H-indol-3-yl)propanamido)-2-methylpropanoic acid |
Frequently asked questions
What are the approved indications of GAL-101?
Approved indications include: Alzheimer's disease, 地图状萎缩, Glaucoma.
When does the GAL-101 patent expire?
No public expiry year is available for GAL-101 yet; this page updates once verified.
How many synthesis routes are recorded for GAL-101?
1 synthesis routes are recorded; the shortest is 3 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy GAL-101 intermediates?
All intermediates in GAL-101 routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for GAL-101 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-22